Slide background
Slide background

Medicinal VIPR Package

ID 8337 | | Visite: 3079 | Documenti Chemicals EntiPermalink: https://www.certifico.com/id/8337

218 19

Medicinal VIPR Package - Lifetime Performance of Drug Delivery Device

EIGA Doc. 218/19

One of the major developments on how medicinal gases are delivered to patients has been the introduction of cylinders fitted with valves that have an integrated pressure regulator.

These medical gas cylinder packages fitted with a valve with integrated pressure regulators (VIPRs) offer a number of significant benefits to both the healthcare professional and the homecare patient when administering the medicinal gas for clinical treatment.

The medical VIPR packages have now been in service for more than twenty years and they have proven to be both reliable and beneficial to those administering medicinal gas from cylinders. Although the medical VIPR packages are used predominantly in medical oxygen service, they can be used for other gases and gas mixtures, including medical air and nitrous oxide/oxygen analgesic gas mixtures.

Although the intended performance of the medical gas VIPR (when initially put into service) is specified in the valve manufacturer’s technical file, the pharmaceutical legislation also requires the gas manufacturer to ensure that the valve is performing correctly each time the cylinder is filled and supplied for patient use over its complete service life. It is important that the VIPR will control the gas supply accurately, as both over and under administration of the gas can lead to patient harm. By establishing a process of valve performance verification and by trending any report received from the customer, it is possible to provide the appropriate assurances that the medical VIPR will function correctly.

This publication is a guideline that describes the basic requirements for the tests that the VIPR manufacturer should perform and the performance checks carried out by the gas manufacturer. This will assist to ensure that the VIPR performs as intended throughout its service life.

This publication applies to filled medicinal VIPR packages used to administer medicinal gases by healthcare professionals and homecare patients.
_________

Table of Contents
Introduction
Scope and purpose
2.1 Scope
2.2 Purpose
Definitions
3.1 Publication terminology
3.2 Technical definitions
Intended performance of medicinal VIPRs
Test requirement for VIPR manufacturers
5.1 General
5.2 Cleaning
5.3 Test conditions for additional tests
5.4 Additional tests to be performed on every medicinal VIPR
Requirements for gas manufacturers
6.1 Initial qualification of a model of VIPR
6.2 Incoming inspection
6.3 VIPR fitting
6.4 First fill
6.5 Post-maintenance fill
Medical VIPR package refilling 
7.1 Pre-fill testing 
7.2 Tests and inspection after filling 
Management of rejected VIPRs at gas manufacturer
Reporting to health authorities 
References 
Other references 
Appendix 1 – Typical Risk Assessment
Appendix 2 - Technical part on medicinal VIPR
Appendix 3 - Flow delivery to the patient
Appendix 4 – Regulatory background

Fonte: EIGA

Collegati:

Descrizione Livello Dimensione Downloads
Allegato riservato Medicinal VIPR Package.pdf
EIGA Doc. 218/19
357 kB 0

Tags: Chemicals Abbonati Chemicals

Articoli correlati

Ultimi archiviati Chemicals

ECHA Annual report 2024
Apr 19, 2025 297

ECHA Annual report 2024

ECHA Annual report 2024 ID 23848 | 19.04.2025 / Attached ECHA’s achievements in 2024 reflect a strong commitment to our strategic goals and priorities, as well as our vision of chemical safety through science, collaboration and knowledge. We continued to progress and implement our existing legal… Leggi tutto
Piano nazionale di controllo ufficiale degli additivi e aromi alimentari 2025 2027
Apr 17, 2025 371

Piano nazionale di controllo ufficiale degli additivi e aromi alimentari 2025-2027

Piano nazionale di controllo ufficiale degli additivi e aromi alimentari 2025-2027 ID 23839 | 17.04.2025 / In allegato Piano nazionale di controllo ufficiale degli additivi e aromi alimentari come materia prima e negli alimenti comprese le sostanze aromatizzanti di affumicatura anni 2025-2027 Il… Leggi tutto
Apr 08, 2025 718

Decreto 27 marzo 2025 | Suppl. 11.7 Farmacopea europea 11ª ed.

Decreto 27 marzo 2025 | Suppl. 11.7 Farmacopea europea 11ª ed. ID 23772 | 08.04.2025 Decreto 27 marzo 2025 Entrata in vigore dei testi, nelle lingue inglese e francese, pubblicati nel supplemento 11.7 della 11ª edizione della Farmacopea europea. (GU n.82 del 08.04.2025) _________ Art. 1. 1. I testi… Leggi tutto
Apr 07, 2025 732

Regolamento delegato (UE) 2025/687

Regolamento delegato (UE) 2025/687 ID 23761 | 07.04.2025 Regolamento delegato (UE) 2025/687 della Commissione, del 30 gennaio 2025, che modifica il regolamento delegato (UE) 2019/624 per quanto riguarda le ispezioni ante mortem presso i macelli, le ispezioni ante mortem presso l’azienda di… Leggi tutto
Mar 20, 2025 839

Regolamento delegato (UE) 2020/1413

Regolamento delegato (UE) 2020/1413 ID 23662 | 20.03.2025 Regolamento delegato (UE) 2020/1413 della Commissione del 29 giugno 2020 che rettifica la versione in lingua svedese dell’allegato I del regolamento (CE) n. 1272/2008 del Parlamento europeo e del Consiglio relativo alla classificazione,… Leggi tutto
IARC Monograph Volume 58
Mar 17, 2025 843

IARC Monographs Volume 58 / 1993

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 58 / IARC 1993 ID 23643 | 17.03.2025 / Attached Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry Evaluates the carcinogenic risk to humans posed by exposure to selected metals and their compounds.… Leggi tutto
Mar 14, 2025 1037

Regolamento (UE) 2024/2929

Regolamento (UE) 2024/2929 ID 23634 | 14.03.2025 Regolamento (UE) 2024/2929 della Commissione, del 27 novembre 2024, che rettifica la versione in lingua francese dell’allegato XVII del regolamento (CE) n. 1907/2006 del Parlamento europeo e del Consiglio per quanto riguarda i livelli di… Leggi tutto
Microbioma nell uomo negli animali negli alimenti e nell ambiente
Mar 14, 2025 801

Microbioma nell’uomo, negli animali, negli alimenti e nell’ambiente

Microbioma nell’uomo, negli animali, negli alimenti e nell’ambiente / Rapporto ISTISAN 2025 ID 23627 | 14.03.2025 / In allegato (EN) Microbioma nell’uomo, negli animali, negli alimenti e nell’ambiente: implicazioni per la valutazione del rischio nella sicurezza alimentare. L’Autorità Europea per la… Leggi tutto

Più letti Chemicals

Notifica HACCP
Apr 05, 2022 98526

Notifica ai fini registrazione Regolamento CE n. 852/2004

Notifica ai fini della registrazione (Reg. CE n. 852/2004) - Ex notifica sanitaria alimentare ID 7901 | 06.03.2019 / Modello notifica allegato [panel]Regolamento (CE) 852/2004...Articolo 6 Controlli ufficiali, registrazione e riconoscimento 1. Gli operatori del settore alimentare collaborano con le… Leggi tutto